<VariationArchive VariationID="503711" VariationName="NM_001099857.5(IKBKG):c.519-3_519dup" VariationType="Duplication" Accession="VCV000503711" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-30" DateCreated="2018-04-02" MostRecentSubmission="2024-03-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495814" VariationID="503711">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001099857.5(IKBKG):c.519-3_519dup</Name>
      <CanonicalSPDI>NC_000023.11:154560403:CAGG:CAGGCAGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154560403" stop="154560404" display_start="154560403" display_stop="154560404" variantLength="4" positionVCF="154560403" referenceAlleleVCF="C" alternateAlleleVCF="CCAGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153788618" stop="153788619" display_start="153788618" display_stop="153788619" variantLength="4" positionVCF="153788618" referenceAlleleVCF="C" alternateAlleleVCF="CCAGG" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153788619_153788622dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153788619_153788622dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154560404_154560407dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154560404_154560407dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.23161_23164dup">
            <Expression>NG_009896.1:g.23161_23164dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377312.1" sequenceAccession="NM_001377312" sequenceVersion="1" change="c.519-3_519dup">
            <Expression>NM_001377312.1:c.519-3_519dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377313.1" sequenceAccession="NM_001377313" sequenceVersion="1" change="c.516-3_516dup">
            <Expression>NM_001377313.1:c.516-3_516dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.723-3_723dup">
            <Expression>NM_001099856.6:c.723-3_723dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321396.3" sequenceAccession="NM_001321396" sequenceVersion="3" change="c.519-3_519dup">
            <Expression>NM_001321396.3:c.519-3_519dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145255.4" sequenceAccession="NM_001145255" sequenceVersion="4" change="c.519-1284_519-1281dup">
            <Expression>NM_001145255.4:c.519-1284_519-1281dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321397.3" sequenceAccession="NM_001321397" sequenceVersion="3" change="c.516-3_516dup">
            <Expression>NM_001321397.3:c.516-3_516dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377314.1" sequenceAccession="NM_001377314" sequenceVersion="1" change="c.516-1284_516-1281dup">
            <Expression>NM_001377314.1:c.516-1284_516-1281dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377315.1" sequenceAccession="NM_001377315" sequenceVersion="1" change="c.400-2406_400-2403dup">
            <Expression>NM_001377315.1:c.400-2406_400-2403dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.5" sequenceAccession="NM_001099857" sequenceVersion="5" change="c.519-3_519dup" MANESelect="true">
            <Expression>NM_001099857.5:c.519-3_519dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.519-3_519dup">
            <Expression>NM_003639.4:c.519-3_519dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.3" sequenceAccession="NM_003639" sequenceVersion="3" change="c.519-3_519dupCAGG">
            <Expression>NM_003639.3:c.519-3_519dupCAGG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_70" sequenceAccession="LRG_70">
            <Expression>LRG_70:g.23161_23164dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.519-3_519dupCAGG">
            <Expression>NM_003639.4:c.519-3_519dupCAGG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799925" DB="ClinGen" />
        <XRef Type="rs" ID="1557236445" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.519-3_519dup AND not provided" Accession="RCV000599176" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.519-3_519dup AND Incontinentia pigmenti syndrome" Accession="RCV003987618" Version="1">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-02" MostRecentSubmission="2024-03-30">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19656162</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24339369</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1389977" SubmissionDate="2018-03-26" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:731262|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000709971" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.519-3_519dupCAGG pathogenic variant in the IKBKG gene has been reported previously in association with Incontinentia Pigmenti (Conte et al., 2014). The duplication causes a frameshift starting with codon Alanine 174, changes this amino acid to a Glutamine residue and creates a premature Stop codon at position 15 of the new reading frame, denoted p.Ala174GlnfsX15. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, this variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.3:c.519-3_519dupCAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3839882</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8982787" SubmissionDate="2024-02-19" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="NM_003639.4:c.519-3_519dupCAGG|MedGen:C0021171" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004803836" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24339369</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19656162</ID>
          </Citation>
          <Comment>Variant summary: IKBKG c.519-3_519dupCAGG involves a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens the canonical 3' acceptor site and creates a new 3' acceptor site, which is expected to result in a frameshift (p.Ala174Glnfs*15). The variant allele was found at a frequency of 9.5e-06 in 104789 control chromosomes (gnomAD and Lee_2009). c.519-3_519dupCAGG has been reported in the literature in the heterozygous state in female individuals affected with Incontinentia Pigmenti (e.g. Lee_2019, Conte_2014). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24339369, 19656162). ClinVar contains an entry for this variant (Variation ID: 503711). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.4:c.519-3_519dupCAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0021171" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14257878</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1389977" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982787" TraitType="Disease" MappingType="XRef" MappingValue="C0021171" MappingRef="MedGen">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

